Recently in AIDS/HIV vaccine Category

HIV vaccine ready for clinical trials

|

clinical trialsA vaccine that is capable of delivering a double whammy against AIDS-causing human immunodeficiency virus by both providing immunity against the infection while at the same time destroying cells infected by the virus is ready for clinical trials, a group of Russian researchers announced today.

The team from Vector State Scientific Center of Virology and Biotechnology, Kol’tsovo, Novosibirsk first reported their research on the CombiHIVvac in the journal Doklady Biochemistry and Biophysics in May 2007.

geovaxATLANTA, February 05, 2007 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. , an Atlanta-based biotechnology company, today reported successful early results from two ongoing AIDS prevention Phase I human vaccine trials. Results from the first low dose trial indicate a good safety profile as well as positive immune responses in human volunteers receiving 1/10th dose of GeoVax's AIDS vaccine.

Results from a second larger full dose trial also indicate a good safety profile in participants. The GeoVax vaccines being tested are designed to prevent the development of Acquired Immunodeficiency Disease ("AIDS") caused by the virus known as HIV-1 by vaccinating individuals prior to infection with the AIDS virus.

The vaccine of new generation against AIDS

|

Russians did it?.. Wow. Great.

Institute of Immunology of Russian Academy of Sciences takes up a problem of AIDS in Russia.

Laboratory chief of physiology of immunity and allergy Georgi Gudia says about a new vaccine against AIDS: "Anti-HIV vaccine HIV - Ripol was developed in the Institute of Immunology". Said vaccine has passed all necessary preclinical trials, and, since 2005, has been passing clinical trials with volunteer attraction.

First trial stage is coming to an end, and medical experts claim they can surely say that the vaccine is harmless and well tolerated for human beings. Ripol vaccine is classified as so-called vaccine of new generation. Ripol is a proprietary development of Institute of Immunology and is unique in global practice; moreover, the vaccine affects not only the antigen, but also its carrier.

A Real-World AIDS Vaccine?

|

Author: Tina Rosenberg

Last month, scientists invented the AIDS vaccine. Missed it? Perhaps that’s because you were still seeking the vaccine fantasy: the magic bullet, the impenetrable shield that finally pitches this disease into the trash bin, the shot that will end not only the AIDS epidemic but our anxiety about the AIDS epidemic as well.

The vaccine thunderbolt didn’t strike — and might never. Drearily, the real AIDS vaccine is likely to be imperfect: one more tool in our arsenal, to be used along with condoms and all our other tools. It will most likely avert millions of infections and save millions of lives. But it will not end the Age of AIDS.

About this Archive

This page is a archive of recent entries in the AIDS/HIV vaccine category.

AIDS Fund Raising is the previous category.

General HIV/AIDS News is the next category.

Find recent content on the main index or look in the archives to find all content.

July 2007: Monthly Archives

Pages

Powered by Movable Type 4.24-en